Inactive Instrument

Insiders Spark Therapeutics, Inc.

Equities

Spark Therapeutics, Inc. Announces Executive Changes, Effective April 1, 2022	22-02-23	CI
Spark Therapeutics Appoints Cynthia Pussinen as Chief Technical Officer	21-02-25	CI
Spark Therapeutics Appoints Michael Retterath as Chief Strategy Officer	20-11-16	CI
Spark Therapeutics, Inc. Appoints Gallia Levy as Chief Medical Officer	20-08-10	CI
Spark Therapeutics, Inc. Announces Board Changes	19-12-17	CI
Spark Therapeutics, Inc. Announces the Resignation of John P. Furey as Chief Operating Officer, Effective January 1, 2019	18-11-15	CI
Spark Therapeutics, Inc. Announces Appointment of Robert J. Perez to the Board of Directors	18-01-04	CI
Spark Therapeutics, Inc. Appoints Federico Mingozzi as Chief Scientific Officer	17-09-25	CI
Spark Therapeutics, Inc. Announces the Resignation of A. Lorris Betz as Board of Director, with Effect from June 30, 2017	17-06-08	CI
Spark Therapeutics Appoints John Furey to Newly Created Position of Chief Operating Officer	16-12-05	CI
Spark Therapeutics, Inc. Hires Dan Faga as Chief Business Officer	16-05-04	CI
Spark Therapeutics, Inc. Names Lota Zoth to the Board of Directors	16-01-06	CI
Spark Therapeutics Appoints Rogerio Vivaldi as Chief Commercial Officer	14-12-16	CI
Spark Therapeutics Announces Board Appointments	14-06-16	CI
Spark Therapeutics, LLC Appoints Elliott Sigal to Board of Directors	14-02-11	CI
Spark Therapeutics Names Dr. Rogerio Vivaldi as Independent Board Member, Effective from April 1, 2014	14-01-21	CI
Spark Therapeutics Announces Executive Appointments	14-01-09	CI

No results for this search